NO20005683L - Ny formulering inneholdende paroxetin - Google Patents

Ny formulering inneholdende paroxetin

Info

Publication number
NO20005683L
NO20005683L NO20005683A NO20005683A NO20005683L NO 20005683 L NO20005683 L NO 20005683L NO 20005683 A NO20005683 A NO 20005683A NO 20005683 A NO20005683 A NO 20005683A NO 20005683 L NO20005683 L NO 20005683L
Authority
NO
Norway
Prior art keywords
formulation containing
new formulation
containing paroxetine
paroxetine
hemihydrate
Prior art date
Application number
NO20005683A
Other languages
English (en)
Other versions
NO20005683D0 (no
Inventor
David Philip Elder
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20005683D0 publication Critical patent/NO20005683D0/no
Publication of NO20005683L publication Critical patent/NO20005683L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Paroxetinhydroklorid, i en annen form enn hemihydratet, som er benyttet i tabletter under betingelser som er slik at det ikke er noen påviselig omdannelse til hemihydrat under tabletteringsprosessen.
NO20005683A 1998-05-13 2000-11-10 Ny formulering inneholdende paroxetin NO20005683L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810181.9A GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations
PCT/GB1999/001520 WO1999058113A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (2)

Publication Number Publication Date
NO20005683D0 NO20005683D0 (no) 2000-11-10
NO20005683L true NO20005683L (no) 2000-12-05

Family

ID=10831927

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005683A NO20005683L (no) 1998-05-13 2000-11-10 Ny formulering inneholdende paroxetin

Country Status (20)

Country Link
EP (1) EP1077682A2 (no)
JP (1) JP2002514591A (no)
KR (1) KR20010043574A (no)
CN (1) CN1308521A (no)
AP (1) AP2000002019A0 (no)
AU (1) AU3940999A (no)
BG (1) BG105010A (no)
BR (1) BR9910401A (no)
CA (1) CA2331871A1 (no)
EA (1) EA200001174A1 (no)
GB (1) GB9810181D0 (no)
HU (1) HUP0102064A2 (no)
ID (1) ID28019A (no)
IL (1) IL139594A0 (no)
NO (1) NO20005683L (no)
PL (1) PL344573A1 (no)
SK (1) SK17142000A3 (no)
TR (1) TR200003350T2 (no)
WO (1) WO1999058113A2 (no)
ZA (1) ZA200006562B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
AU2002330771A1 (en) * 2001-10-22 2003-06-10 Synthon B.V. N-formyl derivatives of paroxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
EA002034B1 (ru) * 1997-01-15 2001-12-24 Смитклайн Бичам Плс Композиция на основе пароксетина
BR9813808A (pt) * 1997-12-19 2002-05-28 Smithkline Beecham Corp Processo para produção de comprimidos para dispersão na mordida

Also Published As

Publication number Publication date
ZA200006562B (en) 2002-02-13
GB9810181D0 (en) 1998-07-08
HUP0102064A2 (hu) 2002-05-29
ID28019A (id) 2001-05-03
WO1999058113A3 (en) 2000-02-17
NO20005683D0 (no) 2000-11-10
TR200003350T2 (tr) 2001-03-21
AP2000002019A0 (en) 2000-12-31
AU3940999A (en) 1999-11-29
BR9910401A (pt) 2001-01-09
WO1999058113A2 (en) 1999-11-18
PL344573A1 (en) 2001-11-05
EP1077682A2 (en) 2001-02-28
SK17142000A3 (sk) 2001-06-11
EA200001174A1 (ru) 2001-06-25
IL139594A0 (en) 2002-02-10
CN1308521A (zh) 2001-08-15
CA2331871A1 (en) 1999-11-18
BG105010A (en) 2001-07-31
KR20010043574A (ko) 2001-05-25
JP2002514591A (ja) 2002-05-21

Similar Documents

Publication Publication Date Title
SE9600071D0 (sv) New oral formulation of two active ingredients I
EE9700189A (et) Mitmikühikuline kihisev annusvorm, mis sisaldab prootonpumba inhibiitorit
DE69626117T2 (de) Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung von reversiblen protonpumpen-inhibitoren
NO20053106D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse.
DK1037634T3 (da) Oral administrationsform som omfatter en protonpumpeinhibitor (fx pantoprazo)
AR080436A2 (es) Preparacion solida de desintegracion rapida, uso de una hidroxipropilcelulosa poco sustituida en dicha preparcion y metodo para mejorar la desintegrabilidad oral de la misma
NO20060416L (no) Ny anvendelse I
NO20002787L (no) Nye forbindelser
DE69623449D1 (de) Thyroxine/zyklodextrinkomplexe und ihre pharmazeutische formulierung
ATE311227T1 (de) Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne
NO20060786L (no) Farmasoytiske preparater med oppsvulmbart belegg
ES2137549T3 (es) Derivados antifungicos de sordaridina.
ATE292453T1 (de) Antivirale arznei
DK1112060T3 (da) Doseringsform anvendende flydende formulering
ATE321538T1 (de) Orale darreichungsform für pyridin-2- ylmethylsulfinyl-1h-benzimidazole
DE50105771D1 (de) Ibuprofen-wirkstoffzubereitung
YU45395A (sh) Novo hemijsko jedinjenje, njegovo pripremanje i njegova primena kao leka
AR042652A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
NO20005681L (no) Nye formuleringer som inneholder paroxetin
NO20005683L (no) Ny formulering inneholdende paroxetin
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
KR890006236A (ko) 피페리디노 알칸올-충혈제거제 조합을 위한 약제학적 조성물
NO920234L (no) Helleformulering for paafoering av antihelmintika
FI853768A0 (fi) Synergistisk sammansaettning som foerhindrar befruktning.
DK1246790T3 (da) Substituerede 1- og 2-naphthol-Mannichbaser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application